Huntington Disease l: Introduction
Pleiotropy
Dysrhythmias III: Characteristics of Dysrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jun 17, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Dominic J Abrams1, Malcolm A Perkin, Jonathan R Skinner
1Department of Cardiac Electrophysiology, St Bartholomew's Hospital and Great Ormond Street Hospital for Children, London, UK. d.abrams@qmul.ac.uk
No abstract available in PubMed .